Emerging at the UK, retatrutide, a novel molecule, is creating considerable buzz within the medical community regarding its potential for weight management . This dual GIP and GLP-1 target agonist appears to provide a significant improvement over established therapies, showing promising results in early clinical assessments. Researchers suggest … Read More